Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Total 13F shares
-
8,153,478
-
Share change
-
+2,000,296
-
Total reported value
-
$41,581,951
-
Put/Call ratio
-
44%
-
Price per share
-
$5.10
-
Number of holders
-
69
-
Value change
-
+$9,667,860
-
Number of buys
-
43
-
Number of sells
-
27
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q2 2023
As of 30 Jun 2023 ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,153,478 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Janney Montgomery Scott LLC, Retirement Planning Co of New England, Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, Mystic Asset Management, Inc., and RENAISSANCE TECHNOLOGIES LLC.
This table shows 69 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.